US budget office reopens comment period on domestic drug production capacity until November 27, 2026
The Office of Management and Budget has reopened its request for information on drug manufacturing capacity in the United States and nearby countries. The window for responses had closed on October 26, 2026, and now stays open until November 27, 2026. The request covers factories that are new or sitting unused, which could make essential medicines, their key ingredients, and starting materials.
This summary was generated by AI; the official source prevails.
What does it mean?
The government is asking companies and others for more time to share details on factories that could make important medicines in the U.S. or nearby. If you have something to say about it, you now have until November 27, 2026.
Who is affected?
Drug makers, suppliers, and other interested parties who could respond to the request.
What changes?
Previously the response deadline was October 26, 2026; now it is November 27, 2026.